Advertisement
Singapore markets closed
  • Straits Times Index

    3,174.11
    -13.55 (-0.43%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,819.50
    -57.55 (-0.73%)
     
  • Bitcoin USD

    64,738.71
    +3,191.19 (+5.18%)
     
  • CMC Crypto 200

    1,330.54
    +17.92 (+1.36%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,398.70
    +0.70 (+0.03%)
     
  • Crude Oil

    83.33
    +0.60 (+0.73%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

My 3 Top Biopharma Stock Picks for 2022

My 3 Top Biopharma Stock Picks for 2022

Thanks to the dual headwinds of sky-high inflation and the threat of rising interest rates, biopharmaceutical stocks appear poised for a turbulent 2022. Underscoring this point, investors have been dumping risky clinical and early commercial-stage biopharma stocks over the past several weeks in response to these closely intertwined macro variables. This year thus seems destined to be a bona fide "stock-picker's market" for biopharma investors.